(Q36306788)

13 August 2017

1 reference

title

The genetics of irritable bowel syndrome (English)

1 reference

13 August 2017

4

Nicholas J Talley

1 reference

13 August 2017

2

Gloria M Petersen

1 reference

13 August 2017

Yuri A Saito

1

1 reference

PubMed ID

16271334

13 August 2017

G Richard Locke

series ordinal

3

1 reference

PubMed ID

16271334

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Clinical Gastroenterology and Hepatology

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

11

1 reference

13 August 2017

1057-1065

1 reference

AGA technical review on irritable bowel syndrome

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Antibiotic use, childhood affluence and irritable bowel syndrome (IBS).

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Is irritable bowel syndrome an inherited disorder? Asking the question right

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Irritable bowel syndrome in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Prevalence of functional bowel disorders and related health care seeking: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

A study of irritable bowel syndrome diagnosed by Manning criteria in an African population

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Epidemiology of irritable bowel syndrome in Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Comparison of bowel patterns in Hispanics and non-Hispanic whites

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Non-colonic features of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Familial association in adults with functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Intergenerational transmission of gastrointestinal illness behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Familial aggregation of irritable bowel syndrome: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

EVIDENCE OF A GENETIC CONTRIBUTION TO FUNCTIONAL BOWEL DISORDER

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Serotonin transporter gene polymorphism in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Serotonin transporter promoter polymorphism in African Americans : allele frequencies and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Functional genomics approaches in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

G-protein beta3 subunit 825T allele and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

A comprehensive review of genetic association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Candidate-gene approaches for studying complex genetic traits: practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900184-9

7 January 2021

10.1016/S1542-3565(05)00184-9

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16271334